Pioneering drug that hits prostate cancer's weak spot

Olaparib works by interfering with a key process that allows some tumour cells to repair themselves, and proved so effective in trials it's now being assessed for NHS use.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news